Featured News
More News
Breakthrough Study led by Edgar Engleman Identifies Key Immune Switch That Could Revolutionize Treatments for Autoimmunity and other diseases
Researchers discover how erythropoietin (EPO) signaling in dendritic cells (cDC1s) regulates immune tolerance, offering new pathways for treating diseases like diabetes and other autoimmune conditions.
Type 1 Diabetes Cured in Groundbreaking Study with mice by SDRC investigators
A novel transplantation strategy resets the immune system and protects replacement islet cells, offering a path to cure Type 1 diabetes.
SDRC Investigators Featured in Stanford Health Magazine’s ‘Breaking the Cycle’ Issue on Chronic Diseases
Discover groundbreaking work from the labs of Drs. Meyer, Snyder, McLaughlin, Maahs, Bhalla, and Robinson TN – read the full article here.
Exciting Study by SDRC Member Phil Beachy Uncovers How Hedgehog Signaling Protects Pancreatic Islets
New research reveals Desert hedgehog signaling (Dhh) from neuroendocrine cells drives epithelial-mesenchymal feedback (EMF) signaling, protecting tissues like airways and pancreatic islets from injury, with implications for therapeutic strategies in airway damage and diabetes.
SDRC Leadership contribute to recent NIDDK Advisory Council Report
Drs. Snyder, Gloyn, and Svensson members of the SDRC participated in the NIDDK Council’s Working Group that has just published a report on the heterogeneity of diabetes. The report outlines key recommendations to advance research and improve understanding of the diverse forms of the disease.
Stanford Medicine endocrinologist Sun H. Kim, MD, MS, and bariatric surgeon Dan Azagury, MD, FACS, break down how GLP-1 medications work, who may benefit, and why they're not a one-size-fits-all solution. [Watch the video →]. Read full Article here.